Paul Ehrlich Laboratories Private Limited
About Paul Ehrlich Laboratories Private Limited
Data last updated:
Paul Ehrlich Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 23 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2015PTC275927. Its GSTIN is 10AAHCP9768N1ZR (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prerna Kumari and Vinay Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 39/A Dda Flats Munirka, New Delhi, Delhi, India – 110067.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.51 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 7.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 10.2%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 39/A Dda Flats Munirka, New Delhi, Delhi, India – 110067
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Paul Ehrlich Laboratories Private Limited
The main business activity of Paul Ehrlich Laboratories is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Paul Ehrlich Laboratories Private Limited FY 2025 filings available
Paul Ehrlich Laboratories Private Limited reported revenue of ₹15.51 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Paul Ehrlich Laboratories Private Limited
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 15%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Paul Ehrlich Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.58 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.17 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Paul Ehrlich Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Paul Ehrlich Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prerna Kumari | Director | 23 Jan 2015 | 11 Years 8 Months | Current |
| Vinay Kumar | Director | 23 Jan 2015 | 11 Years 8 Months | Current |
Peer Comparison of Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acecon Enterprises (India) Private Limited | ₹15.53 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Raipur, Chhattisgarh, India |
| Surya Mart Private Limited | ₹15.52 Lakh (FY 2022) | •••• | •••• | 14.0% | •••• | Pune, Maharashtra, India |
| Futaba Tech Private Limited | ₹15.52 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Potens Impex Private Limited | ₹15.51 Lakh (FY 2020) | •••• | •••• | -42.0% | •••• | Delhi, India |
| Gorgeous Pharma Private Limited | ₹15.51 Lakh (FY 2018) | •••• | •••• | -53.0% | •••• | Delhi, India |
| Paul Ehrlich Laboratories Private Limited this company | ₹15.51 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Murdia Enterprises Private Limited | ₹15.5 Lakh (FY 2019) | •••• | •••• | -42.0% | •••• | Jaipur, Rajasthan, India |
| Vishesh Business Systems Private Limited | ₹15.5 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Delhi, India |
| Fawow Ventures Private Limited | ₹15.5 Lakh (FY 2023) | •••• | •••• | •••• | Kalamassery, Kerala, India | |
| Asap Structured Solutions Private Limited | ₹15.5 Lakh (FY 2025) | •••• | •••• | 1274.0% | •••• | Delhi, India |
| Future Forward Real Estate Private Limited | ₹15.49 Lakh (FY 2017) | •••• | •••• | -26.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Paul Ehrlich Laboratories by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories Private Limited is audited by ABHISHEK KUMAR for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABHISHEK KUMAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Paul Ehrlich Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Paul Ehrlich Laboratories Private Limited
Employment history and EPFO contributions of people linked to Paul Ehrlich Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Prerna Kumari was appointed as Director on 23 Jan 2015.
Credit Ratings, Litigation & Regulatory Alerts for Paul Ehrlich Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Paul Ehrlich Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Paul Ehrlich Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCP9768N1ZR | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Paul Ehrlich Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paul Ehrlich Laboratories Private Limited
Paul Ehrlich Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 23 January 2015 (11+ years old) and is registered under CIN U74999DL2015PTC275927.
Paul Ehrlich Laboratories reported revenue of ₹15.51 Lakh for FY 2025 (up 3% YoY).
Paul Ehrlich Laboratories has 2 current directors:
- Prerna Kumari - Director
- Vinay Kumar - Director
Paul Ehrlich Laboratories reported a net profit of ₹1.17 Lakh (net margin 7.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 10.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Paul Ehrlich Laboratories is -11% over three years and -15% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Paul Ehrlich Laboratories is 10AAHCP9768N1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Paul Ehrlich Laboratories is U74999DL2015PTC275927. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Paul Ehrlich Laboratories was incorporated on 23 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Paul Ehrlich Laboratories by revenue are Acecon Enterprises (India) Private Limited, Surya Mart Private Limited, Futaba Tech Private Limited, Potens Impex Private Limited, Gorgeous Pharma Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Prerna Kumari was appointed as Director on 23 Jan 2015. Vinay Kumar was appointed as Director on 23 Jan 2015.
The registered office of Paul Ehrlich Laboratories is at A – 39A Dda Flats Munirka, New Delhi, Delhi, India – 110067.